Chemical Management

What to Know When Conveying and Feeding Calcium Carbonate in Plastics Compounding

May 11, 2021

This paper outlines the importance of correct design of a conveying and feeding system for calcium carbonate in plastics compounding operations and how it is not a trivial proposition because of the number of variables that affect the flow and different powders.

Spotlight

Celldex Therapeutics

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers, including many underserved or completely un-served orphan indications. This has created a leading pipeline in im

OTHER WHITEPAPERS
news image

THE INTELLIGENT ENTERPRISE FOR THE OIL AND GAS INDUSTRY

whitePaper | April 30, 2021

Learn SAP’s perspective on where the oil and gas industry will go and how SAP contributes to the evolution of the industry in a digital world. SAP Industries White Paper | Oil and Gas© 2021 SAP SE or an SAP affiliate company. All rights reserved. 2“In the experience economy, oil and gas companies that are intelligent enterprises embrace market standards and the cloud to innovate and differentiate.”

Read More
news image

NEW LIFE FOR RECYCLED PLASTIC: CHARACTERIZINGPOSTCONSUMER RESIN WITH MATERIALS ANALYSIS

whitePaper | August 21, 2022

It’s impossible to think about plastics without picturing piles of soda bottles, filmy food wrappers, and other packaging floating in the ocean or washing up on the shore.

Read More
news image

A New Standard in Passive Fire Protection (PFP) Coatings Performance

whitePaper | July 14, 2022

The hydrocarbon industry has strict international testing standards related to the performance of passive fire protective (PFP) coatings for oil and gas platforms, terminals, refineries and other petrochemical facilities.

Read More
news image

Mechanical Vapor Recompression key to steam energy upgrade within a polyolefin plant

whitePaper | September 14, 2022

Reducing energy costs and creating more sustainable local energy sources is a familiar challenge across many industries. Polyolefin process plants, for example, require a considerable amount of energy, often in the form of steam.

Read More
news image

Energy transition and decarbonization Pathways for the chemical industry

whitePaper | August 16, 2022

Like all industries, the chemical sector is under pressure to bring its operations and value chain on track toward a more sustainable and resilient energy future. In the medium and long term.

Read More
news image

Coordination Compounds

whitePaper | May 15, 2022

In the previous Unit we learnt that the transition metals form a large number of complex compounds in which the metal atoms are bound to a number of anions or neutral molecules by sharing of electrons.

Read More

Spotlight

Celldex Therapeutics

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers, including many underserved or completely un-served orphan indications. This has created a leading pipeline in im

Events